Available Technologies
Scalable technology generating iPSCs
with high genomic stability for cell therapy applications.
Scientists at the University of Cambridge have designed a new method of generating iPS cells using blood-derived endothelial progenitors as a substrate. This method proves to be far more efficient than traditional methods of iPS cell differentiation, allowing rapid expansion in culture and large scale production.
